Demonstrates a novel hydrogel coating enhancing antibacterial and lubrication properties in urinary catheters, suggesting a new approach to preventing infections.
Catheter-associated urinary tract infections (CAUTIs) pose a significant challenge, primarily due to biofilm formation on conventional urinary catheters (UCs). Although hydrogels demonstrate favorable biocompatibility, their limited mechanical strength and absence of inherent antibacterial properties have restricted their applications. This study presents a novel polyelectrolyte-induced hydrogel coating for UCs, which integrated silver nanoparticle (AgNP)-loaded alginate (SA)-chitosan (CS) microcapsules (AgNPs@(SA-CS) 5 , referred to as AgSC) within a polyvinyl alcohol (PVA)-polyacrylic acid (PAA)- [2-(methacryloyloxy) ethyl] dimethyl-(3-sulfopropyl) ammonium hydroxide (SBMA) (PPMA) hydrogel matrix. The AgSC microcapsules were synthesized through a layer-by-layer assembly of alginate and chitosan, followed by AgNPs loading and template removal, facilitating sustained antibacterial release. The resulting AgSC-PPMA hydrogel was securely immobilized onto polydopamine-modified UCs (AgSC-PPMA@PUCs). The AgSC-PPMA hydrogel coating exhibited exceptional mechanical properties (storage modulus ∼30,780 Pa; tensile strength 0.16 MPa; toughness 33.71 MJ m −3 ), ultra-low friction (coefficient of friction of 0.014 ± 0.001, which was 1/64 that of pristine UCs), high hydrophilicity (water contact angle 24.3 ± 2.4°), and sustained antibacterial activity (>99.99% against E. coli , K. pneumoniae , and P. aeruginosa ; inhibition zone of 16.0 ± 1.4 mm against E. coli , retained at 13.0 mm after 60 d of thermal aging). Furthermore, the AgSC-PPMA@PUCs demonstrated significant antibiofouling properties (protein adsorption: 7.76 ± 2.86 μg cm −2 ), resistance to bacteria-protein complex adhesion, and excellent biocompatibility (cell viability >70%; hemolysis rate <2%). The AgSC-PPMA@PUC represents a highly promising strategy for preventing CAUTIs, combining enhanced durability, superior lubrication, and robust infection resistance in next-generation medical devices. • Polyelectrolyte-induced crystalline domains significantly enhance hydrogel strength. • Ag-microcapsules enable over 99.99% antibacterial efficiency with 60-day longevity. • The hydrogel coating exhibits ultra-low friction and highly hydrophilic properties. • Protein adsorption of less than 7.8 μg cm −2 and a 66.8% reduction bacterial adhesion. • Clinical safety: cell viability over 70% and hemolysis less than 1%.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: